tradingkey.logo

Globus Medical Inc

GMED
87.810USD
+0.310+0.35%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
11.82BCap. mercado
28.09P/E TTM

Globus Medical Inc

87.810
+0.310+0.35%

Más Datos de Globus Medical Inc Compañía

Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Información de Globus Medical Inc

Símbolo de cotizaciónGMED
Nombre de la empresaGlobus Medical Inc
Fecha de salida a bolsaMar 08, 2012
Director ejecutivoPfeil (Keith W)
Número de empleados5300
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 08
Dirección2560 General Armistead Ave
CiudadAUDUBON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19403
Teléfono16109301800
Sitio Webhttps://www.globusmedical.com/
Símbolo de cotizaciónGMED
Fecha de salida a bolsaMar 08, 2012
Director ejecutivoPfeil (Keith W)

Ejecutivos de Globus Medical Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
+34375.00%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-10000.00%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
10.42K
-2000.00%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--
Mr. Daniel T. (Dan) Lemaitre
Mr. Daniel T. (Dan) Lemaitre
Independent Director
Independent Director
--
-10800.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Director
Independent Director
--
--
Mr. Stephen T. (Steve) Zarrilli
Mr. Stephen T. (Steve) Zarrilli
Independent Director
Independent Director
--
--
Mr. Keith W. Pfeil
Mr. Keith W. Pfeil
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David D. Davidar
Mr. David D. Davidar
Independent Director
Independent Director
685.24K
--
Mr. David C. Paul
Mr. David C. Paul
Executive Chairman of the Board
Executive Chairman of the Board
34.38K
+34375.00%
Mr. Daniel J. Wolterman
Mr. Daniel J. Wolterman
Independent Director
Independent Director
24.02K
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.38K
-10000.00%
Ms. Leslie V. Norwalk
Ms. Leslie V. Norwalk
Independent Director
Independent Director
10.42K
-2000.00%
Mr. Robert Andrew (Rob) Douglas
Mr. Robert Andrew (Rob) Douglas
Independent Director
Independent Director
2.00K
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Musculoskeletal Solutions
741.01M
96.35%
Enabling Technologies
28.04M
3.65%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
617.63M
80.31%
International
151.41M
19.69%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Musculoskeletal Solutions
741.01M
96.35%
Enabling Technologies
28.04M
3.65%

Estadísticas de accionistas

Actualizado: mié., 4 de feb
Actualizado: mié., 4 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.44%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Otro
68.84%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.44%
BlackRock Institutional Trust Company, N.A.
8.68%
Janus Henderson Investors
6.78%
Sculptor Capital Management, Inc
3.14%
State Street Investment Management (US)
3.11%
Otro
68.84%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.06%
Investment Advisor/Hedge Fund
35.89%
Hedge Fund
12.32%
Research Firm
2.10%
Pension Fund
1.90%
Sovereign Wealth Fund
1.09%
Bank and Trust
0.73%
Individual Investor
0.71%
Family Office
0.40%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1059
118.97M
106.78%
-10.87M
2025Q3
1029
117.81M
104.61%
-7.42M
2025Q2
1034
115.30M
102.09%
-12.49M
2025Q1
1057
115.54M
102.35%
-11.15M
2024Q4
1031
113.94M
83.15%
-12.71M
2024Q3
978
112.33M
98.84%
-21.04M
2024Q2
969
117.21M
103.71%
-15.66M
2024Q1
950
117.87M
104.30%
-9.50M
2023Q4
917
111.19M
96.81%
-13.25M
2023Q3
911
113.44M
96.67%
+12.22M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
10.58M
9.5%
-104.01K
-0.97%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.67M
8.68%
-138.27K
-1.41%
Sep 30, 2025
Janus Henderson Investors
7.55M
6.78%
-654.26K
-7.97%
Sep 30, 2025
Sculptor Capital Management, Inc
3.50M
3.14%
+739.31K
+26.78%
Sep 30, 2025
State Street Investment Management (US)
3.46M
3.11%
-11.77K
-0.34%
Sep 30, 2025
Burgundy Asset Management Ltd.
3.46M
3.11%
-20.45K
-0.59%
Sep 30, 2025
JP Morgan Asset Management
3.44M
3.08%
+281.69K
+8.93%
Sep 30, 2025
William Blair Investment Management, LLC
2.82M
2.53%
+414.13K
+17.22%
Sep 30, 2025
Madison Avenue Partners LP
2.55M
2.29%
+836.01K
+48.83%
Sep 30, 2025
Geneva Capital Management LLC
2.08M
1.87%
+1.15K
+0.06%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Nasdaq Lux Digi Health Solutions ETF
2.96%
First Trust Indxx Medical Devices ETF
2.14%
First Trust Health Care Alphadex Fund
1.84%
State Street SPDR S&P Health Care Equipment ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.33%
Invesco S&P MidCap 400 Pure Growth ETF
1.32%
ROBO Global Robotics and Automation Index ETF
1.2%
Global X Guru Index ETF
1.2%
ALPS Disruptive Technologies ETF
0.99%
Pacer US Cash Cows Growth ETF
0.97%
Ver más
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción2.96%
First Trust Indxx Medical Devices ETF
Proporción2.14%
First Trust Health Care Alphadex Fund
Proporción1.84%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.33%
Invesco S&P MidCap 400 Pure Growth ETF
Proporción1.32%
ROBO Global Robotics and Automation Index ETF
Proporción1.2%
Global X Guru Index ETF
Proporción1.2%
ALPS Disruptive Technologies ETF
Proporción0.99%
Pacer US Cash Cows Growth ETF
Proporción0.97%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI